Effects of cyclophosphamide on fertility and general reproductive performance of rats

doi:10.1016/0041-008X(74)90039-8

Toxicology and Applied Pharmacology

Volume 27, Issue 3, March 1974, Pages 602-611

https://doi.org/10.1016/0041-008X(74)90039-8 Get rights and content

Abstract

Cyclophosphamide was administered to male and female rats at 1 or 3 mg/kg/day for 3 successive generations. Except for slight decreases in body weight gain, the general health of the rats, both parental and live offspring, appeared unaffected by treatment. There was a progressive decrease in the number of live births produced in the 3-mg/kg group. Mean total leucocyte values were decreased for both treated groups. Administration of cyclophosphamide to only the male or only the female produced effects which could be expected from cytotoxicity to spermatogenesis or embryonic or fetal toxicity. Although these rats were exposed to cyclophosphamide during embryonic development and for 30 weeks after birth, after 2 weeks' withdrawal from medication, practically complete recovery occurred in the males. A greater and longer residual effect was seen in females.

References (10)

B.L. Oser et al.
Nutritional studies on rats on diets containing high levels of partial ester emulsifiers. II. Reproduction and lactation
J. Nutr.
(1956)
A.G. Wheeler et al.
A toxicologic and hematologic evaluation of cyclophosphamide (Cytoxan^®) in experimental animals
Toxicol. Appl. Pharmacol.
(1962)
M. Bock et al.
The action of triethylenemelamine on the fertility of male rats
Brit. J. Pharmacol.
(1957)
D. Brittinger
The mutagenic action of cyclophosphamide in mice
Humangenetik
(1966)
S. Chaube et al.
Teratogenic effects of cyclophosphamide (NSC-26271) in the rat
Cancer Chem. Rep.
(1967)

There are more references available in the full text version of this article.

Cited by (30)

Evaluation of OECD screening tests 421 (reproduction/developmental toxicity screening test) and 422 (combined repeated dose toxicity study with the reproduction/developmental toxicity screening test)
2003, Regulatory Toxicology and Pharmacology
The Advisory Committee on Existing Chemicals (BUA) of the Federal Republic of Germany convened a panel with expertise in reproductive and developmental toxicology to evaluate the OECD Screening Tests 421 (Reproduction/Developmental Toxicity Screening Test) and 422 (Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Screening Test) with respect to their ability to unmask any potential toxic effects on reproduction. The original assignment for that panel was to “validate” those screening tests. However, the panel members recognized beforehand that this was actually an impossible task because of lack of a sufficient database. Only five chemicals with known reproductive toxicity had been examined following the OECD Screening Test Guidelines 421 or 422. A comparison of these test results with those of the definitive OECD Test Guidelines 414, 415, 416, or additional investigations could, therefore, only have been made with this very limited number of chemicals that had also undergone evaluation by one of the test guidelines cited. In each case biological properties relevant to reproductive toxicity were also indicated by the OECD Screening Tests 421 or 422. This communication reviews the main differences in study design of OECD Screening Test Guidelines 421 and 422 compared to those definitive test guidelines of similar study design for reproduction or developmental toxicity (especially with the one-generation study, OECD Test Guideline 415). The very limited possibilities of detecting late postnatal and postlactational manifestations are emphasized, as is the low statistical power of the OECD Screening Tests 421 and 422. Furthermore, the very limited ability to unmask teratogenicity is delineated. The outcome of screening tests was evaluated based on the results of 57 studies conducted according to the OECD Test Guideline 421 or 422. The test results were categorized according to the incidence of toxic effects on reproduction in the parent animals or their offspring and related to general toxic effects. Based on the ranking of these results, recommendations regarding setting rational priorities for further evaluations of existing chemicals’ reproductive hazards are made. In general, the reviewer panel supports the OECD position that the screening tests are useful for initial hazard assessment and can contribute to the decision-making process on setting priorities for further test requirements. The panel also agrees with the OECD statement that the OECD Screening Tests 421 and 422 are neither an alternative to definitive tests (i.e., OECD Test Guidelines 414, 415, and 416) nor are they intended as their replacement.
The effects of antirheumatic drugs on reproductive function
1997, Reproductive Toxicology
Combined repeat dose and reproductive/developmental toxicity screening test (OECD): Familiarization using cyclophosphamide
1992, Fundamental and Applied Toxicology
A familiarization study was conducted on the “Combined Repeat Dose and Reproductive/Developmental Toxicity Screening Test (ReproTox)¹” proposed by the OECD. Cyclophosphamide (CP) at doses of 6.7, 4.5, 3, 2, and 0 mg/kg body wt was given daily by gavage to groups of 12 male and 12 female Sprague-Dawley rats. As a result, anemia and leukopenia were evident in treated males. The absolute and relative thymus and spleen weights were decreased in treated rats. Histopathologically, atrophy of the thymus, spleen, and bone marrow was observed. With respect to the reproductive/developmental toxicity, dose-dependent increases in postimplantation loss of fetuses and postnatal death were found in dams given CP. The body weight of pups treated with CP was significantly lowered in a dose-related manner. Thus the results demonstrated most of the known toxicological properties of CP, except the adverse effects on spermatogenesis and fertility. Therefore ReproTox can be considered as a useful screening test for assessing repeat dose and reproductive/developmental toxicity of existing chemicals of high production volume.
The short-term reproductive toxicity of cyclophosphamide in the female rat
1991, Reproductive Toxicology
Cyclophosphamide (CTX) is a potent ovarian toxicant. Previous studies of the acute effects of CTX in the rat have demonstrated widespread ovarian follicle atresia, reduced serum estradiol, and progesterone with normal serum LH and FSH. The present investigations demonstrate that a single injection of CTX induces ovarian toxicity that reflects the loss of growing ovarian follicles. CTX induces a sensitization of serum FSH in response to GnRH within 24 h; this sensitization is lost by 7 days, and after 14 days the animals are capable of normal mating behavior. The observed protection of primordial follicles from the acute administration of CTX under these experimental circumstances may be related to the stage of the granulosa cell cycle of these follicles.
Malformed foetuses and karyotype abnormalities in the offspring of cyclophosphamide and allyl alcohol-treated male rats
1990, Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Litters sired by male rats chronically treated with cyclophosphamide (CP) or allyl alcohol (AA), were evaluated for the incidence of foetal malformations and karyotype abnormalities. The male rats were also examied for the induction of deleterious effects on various parameters including those involved in reproductive performance.
A highly significant and consistent increase in the numbers of malformed foetuses was seen in the litters from CP-treated male rats. Chromosome preparations revealed that a large proportion of the malformed foetuses carried karyotypic abnormalities. These effects were paralleled by a large increase in the number of post-implantation losses without significant differences in several sperm and semen characteristics including sperm abnormalities. No adverse reproductive effects were observed with allyl alcohol treatment.
Cyclosphamide in the F<inf>0</inf> male rat: physical and behavioral changes in three successive adult generations
1990, Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

View all citing articles on Scopus

View full text

Effects of cyclophosphamide on fertility and general reproductive performance of rats

Abstract

J. Nutr.

Toxicol. Appl. Pharmacol.

The action of triethylenemelamine on the fertility of male rats

Brit. J. Pharmacol.

The mutagenic action of cyclophosphamide in mice

Humangenetik

Teratogenic effects of cyclophosphamide (NSC-26271) in the rat

Cancer Chem. Rep.